C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,041,217 | -61.6% | 345,969 | -43.0% | 0.03% | -63.0% |
| Q3 2022 | $5,321,000 | +18.1% | 606,721 | +1.6% | 0.08% | +11.0% |
| Q2 2022 | $4,504,000 | -47.5% | 597,374 | +68.8% | 0.07% | -30.5% |
| Q1 2022 | $8,586,000 | -26.1% | 353,912 | -1.9% | 0.10% | -11.8% |
| Q4 2021 | $11,615,000 | -59.5% | 360,710 | -43.8% | 0.12% | -65.0% |
| Q3 2021 | $28,658,000 | +264.8% | 641,399 | +209.0% | 0.34% | +226.9% |
| Q2 2021 | $7,855,000 | – | 207,583 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |